Wikidata

(Q24328949)

English

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

scientific article

In more languages

Statements

title
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan (English)
0 references
author name string
Richard Metz
series ordinal
1
0 references
James B Duhadaway
series ordinal
2
0 references
Uma Kamasani
series ordinal
3
0 references
Lisa Laury-Kleintop
series ordinal
4
0 references
Alexander J Muller
series ordinal
5
0 references
George C Prendergast
series ordinal
6
0 references
publication date
1 August 2007
0 references
volume
67
0 references
page(s)
7082-7
0 references
issue
15
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q24328949&oldid=1946466318"